M Kalaycı, F Cağavi, S Gül, S Yenidünya… - Acta neurochirurgica, 2004 - Springer
Background. Intramedullary spinal cord metastases (ISCM) are rare but, with increasing use of magnetic resonance imaging (MRI) are being encountered with increasing frequency …
D Schiff, BP O'neill - Neurology, 1996 - AAN Enterprises
Our objective was to delineate clinical features and treatment outcome of patients with intramedullary spinal cord metastasis (ISCM). There are no reports of a large experience …
WS Sung, MJ Sung, JH Chan, B Manion, J Song… - World neurosurgery, 2013 - Elsevier
OBJECTIVES: To review previous reports as well as our institutional experience to address the issues regarding patient management and also to assess the predisposing factors that …
P Dam-Hieu, R Seizeur, JF Mineo, JP Metges… - Clinical neurology and …, 2009 - Elsevier
OBJECT: Intramedullary spinal cord metastasis (ISCM) is a rare but devastating complication of cancer. Due to both widespread MRI availability and longer survival of …
U Schick, G Marquardt, R Lorenz - Neurosurgical review, 2001 - Springer
Intradural spinal metastases are uncommon. The outcome of surgical treatment of intra-and extramedullary intradural metastases is considered to be poor, with rapid clinical …
Introduction Intramedullary spinal cord metastases (ISCMs) are rare lesions affecting the spinal cord in patients with disseminated malignancy. Today, due to increased survival …
Diagnosis and management of ductal carcinoma in situ (DCIS). - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
G Scalia, R Costanzo, A Viola, L Bonosi… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Intramedullary spinal cord metastases (ISCM) are deemed extremely aggressive, as confirmed by the low life expectancy since the diagnosis. Up to 26.5% of total …